🚨Attention #Neuroendocrinecancer researchers: NETRF has just launched its first Early Detection Request for Applications (RFA).
Letters of Intent (LOIs) Due: Monday, June 15, 2026, 5 PM ET
Learn more ➡️ https://t.co/DZYgyiW7Rp
Attention #Neuroendocrinecancer Researchers: The @NANETS Basic/Translational Science Investigator Grant sponsored by NETRF (@CureNETs) is open for applications through 6/26/26 Learn more ➡️ https://t.co/CN3NkPh7MO
➡️ EP-NEC patients require expert care from specialists knowledgeable in #neuroendocrine carcinoma
➡️ Generic care is insufficient to address the aggressive nature and unique challenges of this disease
What else do HCPs need to know to support pts w/ extrapulmonary neuroendocrine carcinoma?
📺 Watch the video to find out
From Jessica Thomas, Director of Patient Education at the Neuroendocrine Tumor Research Foundation
🤝Endorsed by @CureNETs & Minkahz NETs Mission
See more of this programme: https://t.co/q0ui5qR6zo
Supported by an Independent Educational Grant from Boehringer Ingelheim
#MedEd #OncTwitter
University of Michigan researchers @yuanyuan_qiao and @ArulChinnaiyan have identified a new target that can suppress tumor growth in gastroenteropancreatic neuroendocrine tumors.
Learn how their findings can be used to develop new treatment methods: https://t.co/Q5D8dWUzxs.
Congratulations to @HuiYu95592845 Hui Yu, MD, PhD, of @CUAnschutz on her NETRF Mentored Research Award award for her research exploring how DIPNECH can progress to lung neuroendocrine tumors.
Learn more: https://t.co/36ftLC94pm
#DIPNECH#LungNETs#NETRFGrantee
Tijana Jovanovic-Talisman, PhD, is among this year's NETRF Pilot Award grantees, and her work to improve diagnostics for #neuroendocrinecancer is deeply personal.
Read more: https://t.co/6BqXKJgfXR
#NETRFGrantee
The NIH/NCI Neuroendocrine Tumor (NET) SPORE @UIHealthcare is accepting Letters of Concept through Mar. 23 for two funding mechanisms aimed at advancing translational NET research. Learn more https://t.co/gud1CLmy1k
#neuroendocrinecancer#NETresearch#grantopportunities
Congratulations to Chiara Mazziotta, PhD, of @DanaFarber on her NETRF Mentored Research Award for her research on Merkel cell carcinoma, a rare neuroendocrine skin cancer.
Learn more about Dr. Mazziotta’s research: https://t.co/WXGzBiWmcV
#NETRFGrantee#Merkelcellcarcinoma
🎉Congratulations to Suzann Duan, PhD, at UC Irvine, on her NETRF Investigator Award for research exploring how aging impacts gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Learn more: https://t.co/ohQ1l21VJZ
#NETRFGrantee#Neuroendocrinecancer#GEP-NETs
Congrats to NETRF Mentored Research Awardee Yeonghwan Kim, PhD, Postdoctoral Fellow at Columbia University, for his research exploring why some #PanNETs resist treatment.
Read more ➡️ https://t.co/JDl2iD0bNd
#NETRFGrantee#NETs#Neuroendocrinecancer
🎉Congratulations to Kirsten Kübler, MD, PhD, on her NETRF Pilot award for her research on the impacts of metaplasia on neuroendocrine neoplasms.
Read more about Dr. Kübler’s research: https://t.co/AxHD1Ea35x
#panNETs#NETRFGrantee#neuroendocrinecancer
🚨 @CureNETs 2026 LOIs are due soon! New this year: dedicated funding for #translationalimmunotherapy, alongside our broad support for NEN research.
💻LOIs due March 16, 2026
📢Learn more: https://t.co/tRYD7Go2YP
🎉Congratulations to NETRF Pilot Award recipient Thomas Walter, MD, PhD (Cancer Research Center of Lyon) who is investigating PRMT5-blocking drugs in NETs in the hopes of identifying new treatments.
Read more ➡️ https://t.co/RwnbXELQ3d
#NETRFGrantee#neuroendocrinecancer
We spoke with Mauro Cives, MD, about his research to transition pancreatic NETS from "immunologically cold" targets to viable candidates for precision cellular immunotherapy.
⬇️ Read more here ⬇️
https://t.co/pACv1HnGt8
#pancsm#PancreaticCancer#Oncology | @cives_mauro
Congratulations to NETRF Pilot Award recipient @tianechen1 , recognized for her work to determine whether GLP-1R expression is linked to tumor aggressiveness and recurrence.
Read more about Dr. Chen’s project ➡️ https://t.co/Qd6FtFrLPi
#neuronendocrinecancer#NETRFGrantee